CHINEDU OBI: Open Payments
NPI 1538626262 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $138 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $61 |
| ABBVIE INC. | 2 | $34 |
| TG Therapeutics, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| MicroTransponder, Inc. | 1 | $29 |
| UCB, Inc. | 1 | $26 |
| Biogen, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Octapharma USA, Inc. | 1 | $20 |
Products named: VYEPTI, BRIUMVI, HYQVIA, Rystiggo, TYSABRI, KESIMPTA, AMYVID, PANZYGA.
Industry payments across TX — which companies pay providers there.
